Clinical presentation of Bacille Calmette-Guerin (BCG) infections following BCG instillation therapy of non-muscle invasive Bladder Cancer

被引:0
|
作者
Nurminen, P. [1 ]
Ettala, O. [1 ]
Uusitalo-Seppala, R. [2 ]
Kaipia, A. [3 ]
Bostrom, P. J. [1 ]
机构
[1] Turku Univ Hosp, Dept Urol, Turku, Finland
[2] Satakunta Hosp Dist, Dept Infect Dis, Pori, Finland
[3] Tampere Univ Hosp, Dept Urol, Tampere, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A0164
引用
收藏
页码:S256 / S257
页数:2
相关论文
共 50 条
  • [1] Clinical presentation of bacille Calmette-Guerin (BCG) infections after BCG instillation therapy
    Nurminen, Pertti
    Ettala, Otto
    Uusitalo-Seppala, Raija
    Hogerman, Mikael
    Kaipia, Antti
    Bostrom, Peter J.
    BJU INTERNATIONAL, 2023, 131 (03) : 306 - 312
  • [2] Incidence of and mortality from Bacille Calmette-Guerin (BCG) infections after BCG instillation therapy
    Nurminen, Pertti
    Ettala, Otto
    Uusitalo-Seppala, Raija
    Nummi, Antti
    Jarvinen, Riikka
    Antti, Kaipia
    Bostrom, Peter J.
    BJU INTERNATIONAL, 2022, 129 (06) : 737 - 743
  • [3] Single instillation of mitomycin C plus bacillus Calmette-Guerin (BCG) versus BCG alone in high grade non-muscle invasive bladder cancer
    Weiss, Brian E.
    Pietzak, Eugene J.
    Wein, Alan J.
    Malkowicz, S. Bruce
    Guzzo, Thomas J.
    CANADIAN JOURNAL OF UROLOGY, 2015, 22 (04) : 7876 - 7881
  • [4] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [5] THE LANDSCAPE OF CLINICALLY ACTIONABLE GENOMIC ALTERATIONS IN PATIENTS WITH BACILLE CALMETTE-GUERIN (BCG) UNRESPONSIVE BLADDER CANCER: TOWARDS TARGETED THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER
    Walasek, Aleksandra
    Almassi, Nima
    McPherson, Victor
    Dason, Shawn
    Benfante, Nicole
    Klein, Tanya
    Berger, Michael
    Schultz, Nikolaus
    Dalbagni, Guido
    Bajorin, Dean
    Rosenberg, Jonathan
    Al-Ahmadie, Hikmat
    Bochner, Bernard
    Solit, David
    Iyer, Gopakumar
    Pietzak, Eugene
    JOURNAL OF UROLOGY, 2019, 201 (04): : E619 - E619
  • [6] SINGLE INSTILLATION OF MITOMYCIN C (MMC) PLUS BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Weiss, Brian
    Wein, Alan
    Malkowicz, S. Bruce
    Guzzo, Thomas
    JOURNAL OF UROLOGY, 2015, 193 (04): : E294 - E294
  • [7] Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies
    Kiselyov, Alex
    Bunimovich-Mendrazitsky, Svetlana
    Startsev, Vladimir
    BBA CLINICAL, 2015, 4 : 27 - 34
  • [8] Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer
    Andrade, Danilo Leite
    Moretti, Tomas Bernardo Costa
    Neto, Wilmar Azal
    Benedetti, Julia
    Reis, Leonardo Oliveira
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1471 - 1476
  • [9] BACILLUS CALMETTE-GUERIN (BCG) THERAPY IS SAFE AND EFFECTIVE IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS WITH IMMUNOSUPPRESSIVE CONDITIONS
    Durant, Adri
    Choudry, Mouneeb
    Madura, Grace
    Mi Lanyu
    Tyson, Mark
    Faraj, Kassem
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S59 - S59
  • [10] Tuberculous Orchitis Following Intravesical Bacille Calmette-Guerin (BCG) Therapy
    Klebanov, Nikolai
    Raghavan, Aravind
    CUREUS, 2018, 10 (05):